Log in
Enquire now
‌

US Patent 10532993 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

Patent 10532993 was granted and assigned to Aerie Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105329930
Patent Inventor Names
Jill Marie Sturdivant0
Mitchell A. deLong0
Susan M. Royalty0
Date of Patent
January 14, 2020
0
Patent Application Number
161388370
Date Filed
September 21, 2018
0
Patent Citations
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
Patent Citations Received
‌
US Patent 12018012 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 11021456 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 11590123 Ophthalmic compositions
‌
US Patent 11618748 Dual mechanism inhibitors for the treatment of disease
‌
US Patent 11707460 Ophthalmic compositions
0
‌
US Patent 11891376 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
Patent Primary Examiner
‌
Kristin A Vajda
0
Patent abstract

Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the invention are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth, such as cancers. The invention further provides compositions containing the beta or gamma-amino isoquinoline amide compounds or substituted benzamide compounds.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10532993 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.